Perkins Coie was mentioned as counsel for Mylan Inc. in "AstraZeneca Can't Stop Mylan's Generic Nexium At Fed. Circ.," a Law360 article, regarding AstraZeneca AB’s attempt to block Mylan Inc.’s generic version of Nexium.